Insider · CIK 0002125950
David Cain
Files at KZIA (KAZIA THERAPEUTICS LTD). First filing -, latest -.
In brief
David Cain files SEC Form 4 as officer at KZIA (KAZIA THERAPEUTICS LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Cain has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | KZIA KAZIA THERAPEUTICS LTD | AGrant or award Employee Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jul 8, 2026 |
Questions about David Cain
Answered from the filings on this page, as of the latest one.
Is David Cain buying or selling?
David Cain has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Cain's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Cain has 0.
Where does David Cain file Form 4?
David Cain has filed Form 4 at KZIA (KAZIA THERAPEUTICS LTD) as Director, CMC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.